Search by Drug Name or NDC
NDC 00641-6020-10 Duramorph 0.5 mg/mL Details
Duramorph 0.5 mg/mL
Duramorph is a EPIDURAL; INTRATHECAL; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is MORPHINE SULFATE.
MedlinePlus Drug Summary
Morphine injection is used to relieve moderate to severe pain. Morphine is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
Related Packages: 00641-6020-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Morphine Injection
Product Information
| NDC | 00641-6020 |
|---|---|
| Product ID | 0641-6020_423b55d6-92db-4e29-a31b-279a6bafbd12 |
| Associated GPIs | 65100055102050 |
| GCN Sequence Number | 052245 |
| GCN Sequence Number Description | morphine sulfate/PF AMPUL 0.5 MG/ML INJECTION |
| HIC3 | H3A |
| HIC3 Description | OPIOID ANALGESICS |
| GCN | 19827 |
| HICL Sequence Number | 025277 |
| HICL Sequence Number Description | MORPHINE SULFATE/PF |
| Brand/Generic | Brand |
| Proprietary Name | Duramorph |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | morphine sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | EPIDURAL; INTRATHECAL; INTRAVENOUS |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | MORPHINE SULFATE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| Marketing Category | NDA |
| Application Number | NDA018565 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00641-6020-10 (00641602010)
| NDC Package Code | 0641-6020-10 |
|---|---|
| Billing NDC | 00641602010 |
| Package | 10 AMPULE in 1 CARTON (0641-6020-10) / 10 mL in 1 AMPULE (0641-6020-01) |
| Marketing Start Date | 1984-09-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |